WeVote
Log In

Bill

Bill

HR 6214

Kidney Care Access Protection Act

119th Congress Introduced by Troy Carter and 13 co-sponsors

HR 6214: End-Stage Renal Disease Treatment Improvement Act OverviewBill Number: HR 6214 Title: To amend title XVIII of the Social Security Act to improve access to innovative trea

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 6214

HR 6214: End-Stage Renal Disease Treatment Improvement Act

Overview

Bill Number: HR 6214
Title: To amend title XVIII of the Social Security Act to improve access to innovative treatment options for end-stage renal disease under the Medicare program, and for other purposes.
Status: Introduced in House
Introduced: November 20, 2025

Purpose and Intent

The primary goal of this bill is to enhance access to innovative treatment options for Medicare beneficiaries with end-stage renal disease (ESRD). The legislation aims to address the significant challenges faced by ESRD patients in obtaining the most advanced therapies and technologies, which can improve their quality of life and health outcomes.

Key Provisions

  • Expands Medicare coverage for home dialysis and self-care dialysis treatments, including the use of wearable or implantable artificial kidneys.
  • Establishes a new payment model for ESRD care, incentivizing the use of innovative therapies and technologies that can reduce hospitalizations and improve patient outcomes.
  • Directs the Centers for Medicare & Medicaid Services (CMS) to develop and implement a comprehensive ESRD care management program, including care coordination, patient education, and support services.
  • Requires CMS to regularly review and update the ESRD treatment and technology coverage policies to ensure they reflect the latest advancements in the field.
  • Provides funding for research and development of new ESRD treatments and technologies, as well as grants to support the adoption and implementation of these innovations.

Affected Parties and Impacts

This bill would primarily benefit Medicare beneficiaries with end-stage renal disease, who would have improved access to cutting-edge treatment options and technologies. It would also impact healthcare providers, dialysis facilities, and medical device manufacturers, as they would need to adapt to the new payment models and coverage policies.

Procedural and Timeline Considerations

The bill has been introduced in the House of Representatives and is currently under consideration by the relevant committees. If passed by the House and Senate, and signed into law by the President, the provisions of the bill would be implemented over a multi-year period, with the new payment models and coverage policies phased in gradually to allow for a smooth transition.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.